Skip to content

Tectonic Therapeutics TECX Interest coverage

Interest coverage at other companies

ALN
Alnylam PharmaceuticalsALNY
3.4×+2.9×
Regenxbio logo
RegenxbioRGNX
-5.7×-1.3×
Opko Health logo
Opko HealthOPK
-1×-0.4×
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-10.8×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
18.1×+12.5×
Precigen logo
PrecigenPGEN
-22,521.4×-22,838×

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Calculated from Tectonic Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's interest coverage?
Tectonic Therapeutics (TECX) reported interest coverage of -1,824.3× in Q1 2026.
How has Tectonic Therapeutics's interest coverage changed year-over-year?
Tectonic Therapeutics's interest coverage decreased by 173.6% year-over-year, from -666.8× to -1,824.3×.
What is the long-term trend for Tectonic Therapeutics's interest coverage?
Over 2 years (2023 to 2025), Tectonic Therapeutics's interest coverage has grown at a 91.4% compound annual growth rate (CAGR), from -364.1× to -1,333.9×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.